STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells.

ATP-Binding Cassette A3 (ABCA3) is a lamellar body associated lipid transport protein required for normal synthesis and storage of pulmonary surfactant in type II cells in the alveoli. In this study, we demonstrate that STAT3, activated by IL-6, regulates ABCA3 expression in vivo and in vitro. ABCA3 mRNA and immunostaining were decreased in adult mouse lungs in which STAT3 was deleted from the respiratory epithelium (Stat3(Delta/Delta) mice). Consistent with the role of STAT3, intratracheal IL-6 induced ABCA3 expression in vivo. Decreased ABCA3 and abnormalities in the formation of lamellar bodies, the intracellular site of surfactant lipid storage, were observed in Stat3(Delta/Delta) mice. Expression of SREBP1a and 1c, SCAP, ABCA3, and AKT mRNAs was inhibited by deletion of Stat3 in type II cells isolated from Stat3(Delta/Delta) mice. The activities of PI3K and AKT were required for normal Abca3 gene expression in vitro. AKT activation induced SREBP expression and increased the activity of the Abca3 promoter in vitro, consistent with the role of STAT3 signaling, at least in part via SREBP, in the regulation of ABCA3. ABCA3 expression is regulated by IL-6 in a pathway that includes STAT3, PI3K, AKT, SCAP, and SREBP. Activation of STAT3 after exposure to IL-6 enhances ABCA3 expression, which, in turn, influences pulmonary surfactant homeostasis.

[1]  Jeffrey A Whitsett,et al.  Gene expression and biological processes influenced by deletion of Stat3 in pulmonary type II epithelial cells , 2007, BMC Genomics.

[2]  N. Cheong,et al.  ABCA3 Is Critical for Lamellar Body Biogenesis in Vivo* , 2007, Journal of Biological Chemistry.

[3]  H. Arai,et al.  ABCA3 as a Lipid Transporter in Pulmonary Surfactant Biogenesis* , 2007, Journal of Biological Chemistry.

[4]  R. Xavier,et al.  ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerols⃞ Published, JLR Papers in Press, December 1, 2006. , 2007, Journal of Lipid Research.

[5]  J. Whitsett,et al.  Expression of ABCA3 in Developing Lung and Other Tissues , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  松崎 陽平.  Stat3 is required for cytoprotection of the respiratory epithelium during adenoviral infection , 2007 .

[7]  S. Wert,et al.  ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease. , 2006, Seminars in perinatology.

[8]  J. Neilson,et al.  Calcineurin/Nfat signaling is required for perinatal lung maturation and function. , 2006, The Journal of clinical investigation.

[9]  Ximing Du,et al.  Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. , 2006, Molecular biology of the cell.

[10]  Julian Downward,et al.  PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP , 2005, Oncogene.

[11]  C. Watson,et al.  The Jak/Stat Pathway: A Novel Way to Regulate PI3K Activity , 2005, Cell cycle.

[12]  J. Whitsett,et al.  Surfactant protein D influences surfactant ultrastructure and uptake by alveolar type II cells. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[13]  J. Whitsett,et al.  Genetic disorders of surfactant homeostasis. , 2005, Biology of the neonate.

[14]  K. Ueda,et al.  ABC proteins: key molecules for lipid homeostasis , 2005, Medical Molecular Morphology.

[15]  I. Yoshida,et al.  Expression of ABCA3, a causative gene for fatal surfactant deficiency, is up-regulated by glucocorticoids in lung alveolar type II cells. , 2004, Biochemical and biophysical research communications.

[16]  J. Whitsett,et al.  ABCA3 gene mutations in newborns with fatal surfactant deficiency. , 2004, The New England journal of medicine.

[17]  S. Akira,et al.  Stat-3 is required for pulmonary homeostasis during hyperoxia. , 2004, The Journal of clinical investigation.

[18]  L. D. Nielsen,et al.  Keratinocyte growth factor and the transcription factors C/EBPα, C/EBPδ, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells , 2003 .

[19]  A. Jobe,et al.  Surfactant protein B inhibits endotoxin-induced lung inflammation. , 2003, American journal of respiratory cell and molecular biology.

[20]  L. D. Nielsen,et al.  Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells. , 2003, The Journal of clinical investigation.

[21]  J. Shannon,et al.  Maintenance of the mouse type II cell phenotype in vitro. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[22]  A. Fisher,et al.  Identification of LBM180, a Lamellar Body Limiting Membrane Protein of Alveolar Type II Cells, as the ABC Transporter Protein ABCA3* , 2002, The Journal of Biological Chemistry.

[23]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[24]  Cong Yan,et al.  Transcriptional Stimulation of the Surfactant Protein B Gene by STAT3 in Respiratory Epithelial Cells* , 2002, The Journal of Biological Chemistry.

[25]  B. Gao,et al.  Role of keratinocyte growth factor in regulating lipogenesis in alveolar type II cells: a gene-profiling approach. , 2002, Chest.

[26]  O. Kawanami,et al.  ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells1 , 2001, FEBS letters.

[27]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[28]  R. Homer,et al.  Interleukin-6-induced protection in hyperoxic acute lung injury. , 2000, American journal of respiratory cell and molecular biology.

[29]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[30]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Elias,et al.  Interleukin-6 protection in hyperoxic lung injury. , 1999, Chest.

[32]  L. McCloud,et al.  Closing pressure rather than opening pressure determines optimal positive end-expiratory pressure and avoids overdistention. , 1999, Chest.

[33]  W. Sellers,et al.  Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Whitsett,et al.  Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. , 1999, American journal of respiratory cell and molecular biology.

[35]  S. Wert,et al.  An En Bloc Staining Protocol Improves The Preservation of Lamellar Bodies in Alveolar Type II Epithelial Cells for Transgenic Mice Expressing Modified Pulmonary Surfactant Protein B , 1998, Microscopy and Microanalysis.

[36]  A. Bardelli,et al.  Induction of epithelial tubules by growth factor HGF depends on the STAT pathway , 1998, Nature.

[37]  S. Akira,et al.  Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. , 1998, Journal of immunology.

[38]  S. Akira,et al.  IL-6-regulated transcription factors. , 1997, The international journal of biochemistry & cell biology.

[39]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[40]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[41]  S. Akira,et al.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  X. Hua,et al.  Sterol Resistance in CHO Cells Traced to Point Mutation in SREBP Cleavage–Activating Protein , 1996, Cell.

[43]  X. Hua,et al.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis , 1994, Cell.

[44]  J. Whitsett,et al.  Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Whitsett,et al.  Increased expression of pulmonary surfactant proteins in oxygen-exposed rats. , 1991, American journal of respiratory cell and molecular biology.

[46]  J. Finkelstein,et al.  Changes in gene expression in hyperoxia-induced neonatal lung injury. , 1990, The American journal of physiology.

[47]  J. Harwood.  Lung surfactant. , 1987, Progress in lipid research.

[48]  L. Smith.  Hyperoxic lung injury: biochemical, cellular, and morphologic characterization in the mouse. , 1985, The Journal of laboratory and clinical medicine.

[49]  R. E. Pattle,et al.  Respiratory Distress in a Newborn Foal with Failure to form Lung Lining Film , 1967, Nature.

[50]  R. Havel,et al.  Composition of surface-active material isolated from beef lung. , 1961, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Curtis.  Hyaline membrane disease. , 1957, The Journal of pediatrics.